Table 2 Patient characteristics
| Â | Non-Diabetic (N = 1,736) | Diabetic (N = 1,000) | P-Value |
|---|---|---|---|
Age (years) | 67 ± 13 | 66 ± 11 | 0.004 |
Men | 1236 (71%) | 726 (73%) | 0.433 |
Killip class (%) | Â | Â | Â |
   I | 1530 (88%) | 791 (79%) | < 0.001 |
   II | 106 (6%) | 85 (9%) |  |
   III | 67 (4%) | 85 (9%) |  |
   IV | 33 (2%) | 39 (4%) |  |
Hypertension | 901 (52%) | 591 (59%) | < 0.001 |
Hyperlipidemia* | 624 (36%) | 472 (47%) | < 0.001 |
Smoking | 944 (54%) | 562 (56%) | 0.356 |
Prior myocardial infarction | 226 (13%) | 188 (19%) | < 0.001 |
Prior percutaneous coronary intervention | 131 (8%) | 98 (10%) | 0.040 |
Left ventricular ejection fraction (%) | 54 ± 13 | 51 ± 13 | < 0.001 |
Number of diseased vessels | Â | Â | Â |
   ≤ 1 | 846 (49%) | 390 (39%) | <0.001 |
   ≥ 2 | 481 (28%) | 322 (32%) |  |
   Undefined | 409 (24%) | 288 (29%) |  |
Onset to reperfusion (hrs)** | 4.5 [3.1-7.0] | 4.6 [3.1-7.8] | 0.881 |
HbA1c (%) | 5.3 ± 0.5 | 7.1 ± 1.6 | <0.001 |
C-reactive protein (mg/dl)** | 0.3 [0.1-0.7] | 0.3 [0.1-0.9] | 0.027 |
Serum creatinine (mg/dl)** | 0.8 [0.7-1.0] | 0.9 [0.7-1.1] | 0.048 |
Concomitant medications | Â | Â | Â |
   Renin-angiotensin system inhibitors | 1095 (63%) | 634 (63%) | 0.866 |
   β-blockers | 522 (30%) | 358 (36%) | 0.002 |
   Calcium antagonists | 489 (28%) | 356 (36%) | < 0.001 |
   Nitrates | 1008 (58%) | 669 (67%) | < 0.001 |
   Aspirin | 1550 (89%) | 881 (88%) | 0.343 |